Literature DB >> 20425632

Management of locally recurrent kidney cancer.

Eric A Singer1, Gennady Bratslavsky.   

Abstract

Locally recurrent kidney cancer is an uncommon but complicated problem. Due to the recognition of the importance of renal preservation and an increase in the use of nephron-sparing approaches via surgery or ablation, locally recurrent disease is being encountered with greater frequency. Treatments for locally recurrent kidney cancer include radical nephrectomy, repeat or salvage partial nephrectomy, de novo or repeat ablation, observation, or experimental systemic therapy. Each of these options has its own constellation of risks and benefits. When local recurrence is detected, the majority of renal units may be saved, but this often comes at the expense of higher perioperative complication rates, which rise with the number of previous interventions on the ipsilateral kidney. Extensive preoperative patient counseling is required to properly individualize therapy. Referral to a center of excellence should be considered before attempting repeat or salvage renal surgery.

Entities:  

Mesh:

Year:  2010        PMID: 20425632     DOI: 10.1007/s11934-009-0085-9

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  46 in total

1.  Laparoscopic versus open radical nephrectomy: a 9-year experience.

Authors:  M D Dunn; A J Portis; A L Shalhav; A M Elbahnasy; C Heidorn; E M McDougall; R V Clayman
Journal:  J Urol       Date:  2000-10       Impact factor: 7.450

2.  Renal cancer in families with hereditary renal cancer: prospective analysis of a tumor size threshold for renal parenchymal sparing surgery.

Authors:  M M Walther; P L Choyke; G Glenn; J C Lyne; W Rayford; D Venzon; W M Linehan
Journal:  J Urol       Date:  1999-05       Impact factor: 7.450

3.  Rising incidence of small renal masses: a need to reassess treatment effect.

Authors:  John M Hollingsworth; David C Miller; Stephanie Daignault; Brent K Hollenbeck
Journal:  J Natl Cancer Inst       Date:  2006-09-20       Impact factor: 13.506

4.  National utilization trends of partial nephrectomy for renal cell carcinoma: a case of underutilization?

Authors:  Brent K Hollenbeck; David A Taub; David C Miller; Rodney L Dunn; John T Wei
Journal:  Urology       Date:  2006-01-25       Impact factor: 2.649

5.  Is radiofrequency ablation safe for solitary kidneys?

Authors:  Kenneth M Jacobsohn; Kamran Ahrar; Christopher G Wood; Surena F Matin
Journal:  Urology       Date:  2007-05       Impact factor: 2.649

6.  The relationship between renal tumor size and metastases in patients with von Hippel-Lindau disease.

Authors:  Branden G Duffey; Peter L Choyke; Gladys Glenn; Robert L Grubb; David Venzon; W Marston Linehan; McClellan M Walther
Journal:  J Urol       Date:  2004-07       Impact factor: 7.450

7.  Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy.

Authors:  Bradley C Leibovich; Michael L Blute; John C Cheville; Christine M Lohse; Amy L Weaver; Horst Zincke
Journal:  J Urol       Date:  2004-03       Impact factor: 7.450

8.  Cancer statistics, 2009.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2009-05-27       Impact factor: 508.702

9.  Initial experience with robot assisted partial nephrectomy for multiple renal masses.

Authors:  Ronald Boris; Miguel Proano; W Marston Linehan; Peter A Pinto; Gennady Bratslavsky
Journal:  J Urol       Date:  2009-08-14       Impact factor: 7.450

10.  Analysis of repeat nephron sparing surgery as a treatment option in patients with a solid mass in a renal remnant.

Authors:  James S Magera; Igor Frank; Christine M Lohse; Bradley C Leibovich; John C Cheville; Michael L Blute
Journal:  J Urol       Date:  2008-01-25       Impact factor: 7.450

View more
  7 in total

1.  Impact of genetics on the diagnosis and treatment of renal cancer.

Authors:  Eric A Singer; Gennady Bratslavsky; Lindsay Middelton; Ramaprasad Srinivasan; W Marston Linehan
Journal:  Curr Urol Rep       Date:  2011-02       Impact factor: 3.092

Review 2.  Repeat partial nephrectomy: surgical, functional and oncological outcomes.

Authors:  Brian Shuch; W Marston Linehan; Gennady Bratslavsky
Journal:  Curr Opin Urol       Date:  2011-09       Impact factor: 2.309

3.  Outcomes of patients with surgically treated bilateral renal masses and a minimum of 10 years of followup.

Authors:  Eric A Singer; Srinivas Vourganti; Kelly Y Lin; Gopal N Gupta; Peter A Pinto; Ardeshir R Rastinehad; W Marston Linehan; Gennady Bratslavsky
Journal:  J Urol       Date:  2012-10-18       Impact factor: 7.450

4.  Familial renal cancer: molecular genetics and surgical management.

Authors:  Glen W Barrisford; Eric A Singer; Inger L Rosner; W Marston Linehan; Gennady Bratslavsky
Journal:  Int J Surg Oncol       Date:  2011-08-22

5.  Advancements in laparoscopic partial nephrectomy: expanding the feasibility of nephron-sparing.

Authors:  Eugene J Pietzak; Thomas J Guzzo
Journal:  Adv Urol       Date:  2012-05-09

6.  Implications of Von Hippel-Lindau Syndrome and Renal Cell Carcinoma.

Authors:  Kenan Ashouri; Sophia Mohseni; John Tourtelot; Pranav Sharma; Philippe E Spiess
Journal:  J Kidney Cancer VHL       Date:  2015-09-25

Review 7.  Modern Management of Localized Renal Cell Carcinoma- Is Ablation Part of the Equation?

Authors:  Zev Leopold; Rachel Passarelli; Mark Mikhail; Alexandra Tabakin; Kevin Chua; Ronald D Ennis; John Nosher; Eric A Singer
Journal:  J Kidney Cancer VHL       Date:  2022-08-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.